OPEN ANGLE GLAUCOMA (OAG)

This study tests an eye drop called QLS-111 in 14 people with diabetic retinopathy or certain types of glaucoma. The goal is to see if it can improve blood flow to the back of the eye. Participants will receive the drops and have their eyes imaged over several weeks.

This study compares two procedures—iStent inject and Kahook Dual Blade goniotomy—both done alongside cataract surgery for people with open-angle glaucoma. The goal is to see which better reduces eye pressure and the need for pressure-lowering drops. About 100 participants will be…

This study tests a device called the VisiPlate aqueous shunt, which is implanted in the eye to help drain fluid and lower eye pressure. It is for people with open-angle glaucoma that hasn't responded well to other treatments. The main goal is to see if the implant can reduce eye …

This study compares two FDA-approved laser treatments for open-angle glaucoma, a condition that damages the optic nerve due to high eye pressure. Both treatments aim to lower eye pressure and prevent vision loss. The newer technique, DSLT, does not require touching the eye and ma…

This study tests an updated inserter for a travoprost implant that is placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. About 30 adults will take part to see if doctors can successfully use the new inserter as instructed. The goal …

This early-stage study tests whether a single dose of ER-100 is safe for adults with open-angle glaucoma or a type of optic nerve stroke called NAION. Researchers will monitor side effects, eye health, and vision over up to 5 years. The goal is to find a safe dose for future stud…